Posts

Gene Therapy in Ophthalmic diseases

Image
  Gene Therapy in Ophthalmic diseases   Gene therapy has emerged as a groundbreaking approach in the treatment of various ophthalmic diseases, particularly those that are inherited or otherwise caused by specific genetic mutations. Here are some of the key aspects and recent advancements in gene therapy related to ophthalmology: 1. Inherited Retinal Diseases Inherited retinal diseases (IRDs) such as retinitis pigmentosa and Leber congenital amaurosis (LCA) are significant targets for gene therapy. These conditions often stem from mutations in specific genes that are crucial for retinal function. Luxturna (voretigene neparvovec) : This was the first FDA-approved gene therapy for an inherited eye disease, designed to treat LCA caused by RPE65 gene mutations. It involves delivering a normal copy of the RPE65 gene directly to retinal cells via an adeno-associated virus (AAV) vector. 2. Age-Related Macular Degeneration (AMD) While most AMD cases are not inherited, gen...

Alcon's Phaco AI and Optimal Energy Settings in Phaco Surgery: Advancing Precision in Biomedical Engineering

  ABSTRACT: In my thesis, I explore the transformative impact of Alcon's Phaco AI on phacoemulsification surgery, focusing on energy optimization to enhance surgical precision and patient safety. I begin by discussing the significance of phaco surgery in ophthalmology and the pressing need for technological advancements in energy management. Through a comprehensive review of the evolution of phaco surgery techniques, I analyze the challenges associated with energy usage, including risks of thermal damage and endothelial cell loss. I then delve into the innovative capabilities of Alcon's Phaco AI, which utilizes real-time data analysis and machine learning algorithms to dynamically adjust energy settings during surgery. My evaluation of recent experimental studies reveals significant improvements in surgical outcomes and efficiency when employing AI-driven systems compared to traditional methods. Furthermore, I address the implications of integrating AI into surgical workflows, ...